Langenbeck's archives of surgery · 2013
Video-assisted selective lateral neck dissection for papillary thyroid carcinoma.
Сравнительное исследованиеСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Wu Bo, Ding Zheng, Fan Youben, Deng Xianzhao, Guo Bomin, Kang Jie, Zhong Chunlin, Yang Zhili, Zheng Qi
Аннотация
BACKGROUND: The minimally invasive video-assisted thyroidectomy (MIVAT) for thyroid benign nodules and central neck dissection (CND) for papillary thyroid microcarcinoma (PTMC) have been applied, presently, we attempted to perform video-assisted selective lateral neck dissection (VASLND) for papillary thyroid carcinoma (PTC).
METHODS: Twenty-six consecutive PTC patients with unilateral tumor (size <4.0 cm) and suspected lymph node metastasis at level III, IV, or IIa were included from March 2009 to January 2012.
RESULTS: VASLND was successfully performed in all 26 PTC patients. The mean operative time was 46 min (range 26-75 min) on VASLND. No major complications occurred. Average postoperative hospital stay was 3.6 days (range 2-8 days). The mean number of removed nodes was 7.3 (range 4-12) in central neck and 8.3 (range 3-21) in lateral compartment. Positive yield amounted to a mean value of 2.6 (range 0-5) and 3 (range 0-6), respectively. No persistent or recurrent disease was observed in any patient during a follow-up period. The cosmetic result was excellent.
CONCLUSIONS: Our initial experience demonstrates that VASLND is feasible and safe for selected PTCs, with superior appearance and less pain. Nevertheless, larger series and comparative studies with longer follow-up could be necessary to confirm its oncological effectiveness.
METHODS: Twenty-six consecutive PTC patients with unilateral tumor (size <4.0 cm) and suspected lymph node metastasis at level III, IV, or IIa were included from March 2009 to January 2012.
RESULTS: VASLND was successfully performed in all 26 PTC patients. The mean operative time was 46 min (range 26-75 min) on VASLND. No major complications occurred. Average postoperative hospital stay was 3.6 days (range 2-8 days). The mean number of removed nodes was 7.3 (range 4-12) in central neck and 8.3 (range 3-21) in lateral compartment. Positive yield amounted to a mean value of 2.6 (range 0-5) and 3 (range 0-6), respectively. No persistent or recurrent disease was observed in any patient during a follow-up period. The cosmetic result was excellent.
CONCLUSIONS: Our initial experience demonstrates that VASLND is feasible and safe for selected PTCs, with superior appearance and less pain. Nevertheless, larger series and comparative studies with longer follow-up could be necessary to confirm its oncological effectiveness.
Предметные рубрики MeSH
AdultAgedBiopsy, NeedleCarcinomaCarcinoma, PapillaryCohort StudiesFemaleFollow-Up StudiesHumansImmunohistochemistryLength of StayLymph Node ExcisionLymph NodesMaleMiddle AgedMinimally Invasive Surgical ProceduresNeck DissectionNeoplasm StagingOperative TimePain MeasurementPatient SafetyPatient SelectionRetrospective StudiesRisk AssessmentThyroid Cancer, PapillaryThyroid NeoplasmsThyroidectomyTomography, X-Ray ComputedTreatment OutcomeVideo-Assisted SurgeryWound HealingYoung Adult